Table 1 anthropometric and clinical characteristics of celiac patients studied at baseline, of patients studied during gluten free diet and of control subjects
Upper GI tract | Celiacs | Controls | |
|---|---|---|---|
Baseline | GFD | ||
n | 38 | 68 | 69 |
F/M | 27/11 | 49/19 | 50/19 |
age (years) | 34.5 ± 4.7 | 36.2 ± 2.2 | 48.9 ± 16.4* |
Marsh | |||
0 | 0 | 2 | 57 |
1 | 0 | 0 | 3 |
2 | 5 | 60 | 8 |
3a | 5 | 5 | 0 |
3b | 5 | 1 | 0 |
3c | 23 | 0 | 0 |
Antibodies (n) | |||
tTg | 17 | 0 | 0 |
EMA | 13 | 0 | 0 |
t-TG + EMA | 8 | 0 | 0 |
HP (n) | |||
positive | 8 | 10 | 13 |
negative | 30 | 58 | 56 |
Upper and lower GI tract | Controls | ||
n | 36 | ||
F/M | 21/15 | ||
age (years) | 51.6 ± 20.5* |